TW200722077A - Composition for enhancing expression and activity of protease in liver - Google Patents
Composition for enhancing expression and activity of protease in liverInfo
- Publication number
- TW200722077A TW200722077A TW095110775A TW95110775A TW200722077A TW 200722077 A TW200722077 A TW 200722077A TW 095110775 A TW095110775 A TW 095110775A TW 95110775 A TW95110775 A TW 95110775A TW 200722077 A TW200722077 A TW 200722077A
- Authority
- TW
- Taiwan
- Prior art keywords
- composition
- protease
- liver
- activity
- enhancing expression
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005093729 | 2005-03-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200722077A true TW200722077A (en) | 2007-06-16 |
Family
ID=37053410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW095110775A TW200722077A (en) | 2005-03-29 | 2006-03-28 | Composition for enhancing expression and activity of protease in liver |
Country Status (2)
| Country | Link |
|---|---|
| TW (1) | TW200722077A (zh) |
| WO (1) | WO2006104154A1 (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007034852A1 (ja) * | 2005-09-22 | 2007-03-29 | Kaneka Corporation | 延命用組成物及び寿命を延長する方法 |
| JPWO2008069276A1 (ja) * | 2006-12-06 | 2010-03-25 | 株式会社カネカ | 癌治療剤および発癌抑制剤 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6118719A (ja) * | 1984-07-06 | 1986-01-27 | Kao Corp | 胆石症治療剤 |
| CA2007983C (en) * | 1989-01-18 | 1996-12-10 | Michael S. Brown | Coenzyme q10 with hmg-coa reductase inhibitors |
| JPH09187229A (ja) * | 1996-01-10 | 1997-07-22 | Idemitsu Material Kk | 家禽用飼料組成物 |
| JP3889481B2 (ja) * | 1996-08-16 | 2007-03-07 | 株式会社カネカ | 医薬組成物 |
| GB9722361D0 (en) * | 1997-10-24 | 1997-12-17 | Pharma Nord Uk Ltd | Pharmaceutical formulation for treating liver disorders |
| WO2000057871A2 (en) * | 1999-03-30 | 2000-10-05 | Purdue Research Foundation | Methods for identifying agents that inhibit serum aging factors and uses and compositions thereof |
| JP2003119127A (ja) * | 2001-10-10 | 2003-04-23 | Kanegafuchi Chem Ind Co Ltd | 安定な還元型補酵素q製剤 |
| TW200524579A (en) * | 2003-11-28 | 2005-08-01 | Kaneka Corp | Composition for protecting liver functions |
-
2006
- 2006-03-28 TW TW095110775A patent/TW200722077A/zh unknown
- 2006-03-28 WO PCT/JP2006/306317 patent/WO2006104154A1/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006104154A1 (ja) | 2006-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA115720S (en) | Lid | |
| TW200744568A (en) | Epinephrine dosing regimens | |
| EP1782803A4 (en) | COMPOSITION WITH COENZYM Q10 | |
| IL181331A0 (en) | Oxazolo-naphthyl acids as plasminogen activator inhibitor type i (pai-1) modulators | |
| CA118086S (en) | Bottle | |
| TW200730513A (en) | Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases | |
| IL187489A (en) | Substrate for rpn11 meteloprotase containing a jamm motif | |
| TW200603785A (en) | Compositions containing reduced coenzyme Q10 and carotenoid | |
| CA118087S (en) | Bottle | |
| CA115648S (en) | Container | |
| IL177055A0 (en) | Silinae compounds as cysteine protease inhibitors | |
| TW200730190A (en) | New combination to treat liver fibrosis | |
| TW200722077A (en) | Composition for enhancing expression and activity of protease in liver | |
| IL192507A0 (en) | Use of alpha-hydroxy carbonyl compounds as reducing agents | |
| CA114230S (en) | Tape cartridge | |
| MX349242B (es) | Formulaciones que comprenden saccharomyces boulardii y superoxido dismutasa para controlar la obesidad. | |
| TW200738244A (en) | 20-Alkyl, gemini vitamin D3 compounds and methods of use thereof | |
| TW200722076A (en) | Composition for increasing anti-oxidation activity in blood | |
| IL173104A0 (en) | Siva and ubiquintination | |
| CA116598S (en) | Combination container and dentifrice | |
| WO2009063521A3 (en) | Composition for topical use to achieve a rapid and intense lifting effect | |
| UA87524C2 (ru) | Бензотиазолсодержащая композиция с макроголглицеридом и ее использование | |
| TW200730289A (en) | Fluxing compositions containing benzotriazoles | |
| SV2007002216A (es) | Nueva combinacion antiparasitaria de principios activos ref. bhc041312-sv | |
| EP1916993A4 (en) | COSMETIC COMPOSITION WITH A PROTEASE ACTIVATOR |